News

June 19, 2018June 19, 2018

PUR0200 Shown to Be as Good as Spiriva HandiHaler for COPD in Phase 1 Trial

News

Pulmatrix‘s branded generic of Spiriva HandiHaler, called PUR0200, was shown to promote similar improvements in lung function in patients with chronic obstructive pulmonary disease (COPD), but at significantly lower doses than Spiriva, ... Read more

June 15, 2018June 15, 2018

Childhood Surgical Removal of Tonsils, Adenoids Increases COPD Risk Later, Study Says

News

The surgical removal of tonsils and adenoids, a common procedure in children, has been linked to an increased risk of respiratory infectious diseases, particularly chronic obstructive pulmonary disease (COPD), ... Read more

June 12, 2018June 12, 2018

Uni-flo2 Single-nasal Cannula System Favored by COPD Patients Using It, Company Reports

News

A patient-satisfaction survey found that the uni-flo2 single-nasal cannula system (Uni-flo2) is considered to be comfortable, stable and secure by 98 percent of those who responded, the system’s developers reported ... Read more

June 5, 2018June 5, 2018

Add-on Treatment with Fasenra Fails to Reduce COPD Worsening in TERRANOVA Trial

News

The investigational monoclonal antibody Fasenra (benralizumab) failed to reduce exacerbations in patients with moderate to very severe chronic obstructive pulmonary disease (COPD), top-line results of the Phase 3 TERRANOVA trial ... Read more

June 1, 2018June 1, 2018

#ATS2018 — New Tool Can Determine Risk of Hospitalization for COPD Patients, Study Finds

News

A newly developed tool can predict patients with chronic obstructive pulmonary disease (COPD) who are at a high risk of hospitalization due to a disease flare-up, according to a study. ... Read more

May 29, 2018May 29, 2018

#ATS2018 — Combined COPD Treatments Could Be Effective Cost-Saving Strategy, Study Says

News

Combining home oxygen therapy (HOT) with home noninvasive ventilation (HMV) could be more effective and less expensive than HOT alone for certain patients with chronic obstructive pulmonary disease (COPD), ... Read more

May 25, 2018May 25, 2018

Zephyr Endobronchial Valve Improves Breathing in Severe Emphysema, Study Finds

News

The Zephyr Endobronchial Valve, Pulmonx’s minimally invasive treatment for severe emphysema, was recently found to improve breathing, quality of life, and activity for patients in a U.S. clinical trial ... Read more

May 22, 2018May 22, 2018

Large-scale Study Finds that 21% of COPD Cases Can Be Attributed to Occupational Exposures

News

A new study showed that 21% of chronic obstructive pulmonary disease (COPD) cases can be attributed to occupational exposures, particularly exposure to biological dust, pesticides, gases, and fumes. The study, ... Read more

May 18, 2018May 18, 2018

AstraZeneca’s Fasenra Fails to Reduce COPD Exacerbations, Phase 3 Trial Shows

News

Top-line results of a Phase 3 trial showed that treatment candidate Fasenra (benralizumab) failed to reduce exacerbations in patients with moderate to very severe chronic obstructive pulmonary disease (COPD), AstraZeneca ... Read more

May 15, 2018May 15, 2018

#ATS2018 – Potential COPD Treatment, RPL554, Seen to Aid Bronchodilation in Combo with Spiriva

News

Verona Pharma’s treatment candidate for chronic obstructive pulmonary disease (COPD) RPL554 works to open the airways of the lungs, aiding bronchodilation, when used with Spiriva (tiotropium), and its newer inhaled formulation is ... Read more

Pin It on Pinterest